Skip to content

Clinical trials

Digestive System Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Digestive System Diseases Clear all

405 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20023
20031
20052
20061
20079
200810
200921
201011
201120
201210
201319
201420
201511
201615
201726
201826
201915
202024
202133
202233
202326
202425
202521
202619

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed212
Recruiting54
Unknown status49
Terminated31
Active, not recruiting26
Not yet recruiting12
Withdrawn11
Enrolling by invitation5
Approved for marketing3
Suspended2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences9
Assistance Publique - Hôpitaux de Paris6
Exact Sciences Corporation6
M.D. Anderson Cancer Center5
Mirum Pharmaceuticals, Inc.5
Boston Scientific Corporation4
Celgene4
Mayo Clinic4
Novartis Pharmaceuticals4
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Digestive System Diseases405
Gastrointestinal Diseases120
Intestinal Diseases82
Digestive System Neoplasms64
Neoplasms64
Liver Diseases56
Gastrointestinal Neoplasms53
Colonic Diseases51
Neoplasms by Site49
Colorectal Neoplasms40

Trials

Showing 76 to 100 of 405. Each trial links to its page on Pharma Observatory.

305 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.